94 related articles for article (PubMed ID: 32817957)
1. Functional SARS-CoV-2-specific immune memory persists after mild COVID-19.
Rodda LB; Netland J; Shehata L; Pruner KB; Morawski PM; Thouvenel C; Takehara KK; Eggenberger J; Hemann EA; Waterman HR; Fahning ML; Chen Y; Rathe J; Stokes C; Wrenn S; Fiala B; Carter LP; Hamerman JA; King NP; Gale M; Campbell DJ; Rawlings D; Pepper M
medRxiv; 2020 Aug; ():. PubMed ID: 32817957
[TBL] [Abstract][Full Text] [Related]
2. Functional SARS-CoV-2-specific immune memory persists after mild COVID-19.
Rodda LB; Netland J; Shehata L; Pruner KB; Morawski PA; Thouvenel C; Takehara KK; Eggenberger J; Hemann E; Waterman HR; Fahning ML; Chen Y; Rathe J; Stokes C; Wrenn S; Fiala B; Carter L; Hamerman JA; King NP; Gale M; Campbell DJ; Rawlings D; Pepper M
Res Sq; 2020 Aug; ():. PubMed ID: 32818218
[TBL] [Abstract][Full Text] [Related]
3. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.
Rodda LB; Netland J; Shehata L; Pruner KB; Morawski PA; Thouvenel CD; Takehara KK; Eggenberger J; Hemann EA; Waterman HR; Fahning ML; Chen Y; Hale M; Rathe J; Stokes C; Wrenn S; Fiala B; Carter L; Hamerman JA; King NP; Gale M; Campbell DJ; Rawlings DJ; Pepper M
Cell; 2021 Jan; 184(1):169-183.e17. PubMed ID: 33296701
[TBL] [Abstract][Full Text] [Related]
4. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
[TBL] [Abstract][Full Text] [Related]
5. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG.
Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G
Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing antibodies mediate virus-immune pathology of COVID-19.
Jacobs JJL
Med Hypotheses; 2020 Oct; 143():109884. PubMed ID: 32512289
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of viral load and antibody response in relation to COVID-19 severity.
Wang Y; Zhang L; Sang L; Ye F; Ruan S; Zhong B; Song T; Alshukairi AN; Chen R; Zhang Z; Gan M; Zhu A; Huang Y; Luo L; Mok CKP; Al Gethamy MM; Tan H; Li Z; Huang X; Li F; Sun J; Zhang Y; Wen L; Li Y; Chen Z; Zhuang Z; Zhuo J; Chen C; Kuang L; Wang J; Lv H; Jiang Y; Li M; Lin Y; Deng Y; Tang L; Liang J; Huang J; Perlman S; Zhong N; Zhao J; Malik Peiris JS; Li Y; Zhao J
J Clin Invest; 2020 Oct; 130(10):5235-5244. PubMed ID: 32634129
[TBL] [Abstract][Full Text] [Related]
9. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.
Hartley GE; Edwards ESJ; Aui PM; Varese N; Stojanovic S; McMahon J; Peleg AY; Boo I; Drummer HE; Hogarth PM; O'Hehir RE; van Zelm MC
Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33443036
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals.
Mazzoni A; Maggi L; Capone M; Vanni A; Spinicci M; Salvati L; Tekle Kiros S; Semeraro R; Pengue L; Colao MG; Magi A; Rossolini GM; Liotta F; Cosmi L; Bartoloni A; Annunziato F
Clin Transl Immunology; 2021; 10(5):e1281. PubMed ID: 33976879
[TBL] [Abstract][Full Text] [Related]
12. Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection.
Jiang XL; Wang GL; Zhao XN; Yan FH; Yao L; Kou ZQ; Ji SX; Zhang XL; Li CB; Duan LJ; Li Y; Zhang YW; Duan Q; Wang TC; Li ET; Wei X; Wang QY; Wang XF; Sun WY; Gao YW; Kang DM; Zhang JY; Ma MJ
Nat Commun; 2021 Feb; 12(1):897. PubMed ID: 33563974
[TBL] [Abstract][Full Text] [Related]
13. Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients.
Yang LT; Peng H; Zhu ZL; Li G; Huang ZT; Zhao ZX; Koup RA; Bailer RT; Wu CY
Clin Immunol; 2006 Aug; 120(2):171-8. PubMed ID: 16781892
[TBL] [Abstract][Full Text] [Related]
14. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration.
Newell KL; Clemmer DC; Cox JB; Kayode YI; Zoccoli-Rodriguez V; Taylor HE; Endy TP; Wilmore JR; Winslow GM
PLoS One; 2021; 16(1):e0244855. PubMed ID: 33507994
[TBL] [Abstract][Full Text] [Related]
15. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.
Ni L; Ye F; Cheng ML; Feng Y; Deng YQ; Zhao H; Wei P; Ge J; Gou M; Li X; Sun L; Cao T; Wang P; Zhou C; Zhang R; Liang P; Guo H; Wang X; Qin CF; Chen F; Dong C
Immunity; 2020 Jun; 52(6):971-977.e3. PubMed ID: 32413330
[TBL] [Abstract][Full Text] [Related]
16. Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak.
Har-Noy M; Or R
J Transl Med; 2020 May; 18(1):196. PubMed ID: 32398026
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
Le Bert N; Tan AT; Kunasegaran K; Tham CYL; Hafezi M; Chia A; Chng MHY; Lin M; Tan N; Linster M; Chia WN; Chen MI; Wang LF; Ooi EE; Kalimuddin S; Tambyah PA; Low JG; Tan YJ; Bertoletti A
Nature; 2020 Aug; 584(7821):457-462. PubMed ID: 32668444
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.
Mazzoni A; Maggi L; Capone M; Spinicci M; Salvati L; Colao MG; Vanni A; Kiros ST; Mencarini J; Zammarchi L; Mantengoli E; Menicacci L; Caldini E; Romagnani S; Liotta F; Morettini A; Rossolini GM; Bartoloni A; Cosmi L; Annunziato F
Eur J Immunol; 2020 Dec; 50(12):2013-2024. PubMed ID: 33080068
[TBL] [Abstract][Full Text] [Related]
19. Immunity to SARS-CoV-2 up to 15 months after infection.
Marcotte H; Piralla A; Zuo F; Du L; Cassaniti I; Wan H; Kumagai-Braesh M; Andréll J; Percivalle E; Sammartino JC; Wang Y; Vlachiotis S; Attevall J; Bergami F; Ferrari A; Colaneri M; Vecchia M; Sambo M; Zuccaro V; Asperges E; Bruno R; Oggionni T; Meloni F; Abolhassani H; Bertoglio F; Schubert M; Calzolai L; Varani L; Hust M; Xue Y; Hammarström L; Baldanti F; Pan-Hammarström Q
iScience; 2022 Feb; 25(2):103743. PubMed ID: 35018336
[TBL] [Abstract][Full Text] [Related]
20. Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients.
Flehmig B; Schindler M; Ruetalo N; Businger R; Bayer M; Haage A; Kirchner T; Klingel K; Normann A; Pridzun L; Tougianidou D; Ranke MB
Viruses; 2020 Nov; 12(12):. PubMed ID: 33260809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
